Literature DB >> 16965730

Electrical stimulation of the carotid sinus for the treatment of resistant hypertension.

J D Filippone1, James A Sloand, Karl A Illig, John D Bisognano.   

Abstract

Hypertension is a major cause of morbidity and mortality worldwide. Despite a myriad of oral agents, many patients fail to reach their target blood pressure. Electrical stimulation of the carotid sinus, an old therapeutic concept, lowers blood pressure by initiating the baroreflex and reducing sympathetic tone. Recent evidence suggests that the baroreflex is more important in the setting of chronic hypertension than originally believed. The carotid stimulator may be a safe and effective therapeutic option for patients with resistant hypertension.

Entities:  

Mesh:

Year:  2006        PMID: 16965730     DOI: 10.1007/s11906-006-0089-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  35 in total

1.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

Review 2.  The sympathetic nervous system in renovascular hypertension: lead actor or 'bit' player?

Authors:  Guido Grassi; Murray Esler
Journal:  J Hypertens       Date:  2002-06       Impact factor: 4.844

3.  Baroceptor function in chronic renal hypertension.

Authors:  J W MCCUBBIN; J H GREEN; I H PAGE
Journal:  Circ Res       Date:  1956-03       Impact factor: 17.367

4.  Prolonged activation of the baroreflex abolishes obesity-induced hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Eric D Irwin; Martin A Rossing; Robert S Kieval
Journal:  Hypertension       Date:  2007-04-16       Impact factor: 10.190

5.  Diminished baroreflex sensitivity in high blood pressure.

Authors:  J D Bristow; A J Honour; G W Pickering; P Sleight; H S Smyth
Journal:  Circulation       Date:  1969-01       Impact factor: 29.690

6.  Baroreflexes prevent neurally induced sodium retention in angiotensin hypertension.

Authors:  T E Lohmeier; J R Lohmeier; A Haque; D A Hildebrandt
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

7.  Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

Authors:  Jan A Staessen; Ji-Guang Wang; Lutgarde Thijs
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

8.  Prolonged activation of the baroreflex produces sustained hypotension.

Authors:  Thomas E Lohmeier; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

Review 9.  Baroreflex failure: a neglected type of secondary hypertension.

Authors:  H J L M Timmers; W Wieling; J M Karemaker; J W M Lenders
Journal:  Neth J Med       Date:  2004-05       Impact factor: 1.422

10.  Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men.

Authors:  Samy I McFarlane; Jonathan Castro; Jasjeet Kaur; John J Shin; Douglas Kelling; Amal Farag; Nicole Simon; Fadi El-Atat; Alan Sacerdote; Emad Basta; John Flack; George Bakris; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738

View more
  2 in total

Review 1.  Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure.

Authors:  Michael Doumas; Charles Faselis; Costas Tsioufis; Vasilios Papademetriou
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

2.  Improved control of resistant hypertension with device-mediated electrical carotid sinus baroreflex stimulation.

Authors:  James A Sloand; Karl A Illig; John D Bisognano
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-09       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.